Friday, January 29, 2016

CALL FOR APPLICATIONS WSO Young Stroke Professionals Brief Clinical Exchange Scholarship Program




CALL FOR APPLICATIONS
WSO Young Stroke Professionals Brief Clinical Exchange Scholarship Program
Purpose:
To support young stroke professionals from any discipline to spend a 1-2 week observership at an international center of excellence in order to foster best clinical practice benchmarking and collaborative research.
Nature of support:
Up to 5 scholarships will be awarded each year to cover travel and accommodation up to US$2000 per scholarship, to be reimbursed by WSO on presentation of receipts and short travel reports from both observer and host. The host institution is expected to waive any observership fees.
Application and selection process:
Applications are restricted to current WSO members. Applications will be judged by the WSO Young Stroke Professionals Committee based on merit with 2 of the 5 positions weighted towards young stroke professionals from low-middle income countries. The applicants should generally be below 40 years of age.
The application should include:
  • curriculum vitae 
  • provisional budget for travel and accommodation to the proposed institution 
  • written confirmation from the proposed institution agreeing to the visit 
  • a 500 word statement explaining how this visit will aid the young stroke professional’s career
Closing Date:
Applications for the 2016 round (for travel by end of 2016) must be lodged with the WSO via email (admin@world-stroke.org) by 5th February 2016
For further information contact Dr Bruce Campbell, WSO Young Stroke Professionals Committee (bruce.campbell@mh.org.au)


Monday, January 25, 2016

Seven Minutes in Stroke - Liam Johnson

Seven minutes in stroke 


1. What inspired you towards neuroscience?

During my undergraduate studies in Exercise and Sports Science, I completed a motor control and development unit where I studied the link between movement and the central nervous system (CNS), and what happens when the CNS, and in particular the brain, is injured or diseased. This ignited a passion in me to try to understand as much as I could about this link between the brain and movement, and in particular, how exercise can be used to help people recover from, or deal with, neurological or neuromuscular conditions.

2. Why stroke? 

One in 6 Australians will experience a stroke in their lifetime, and many of them will be left with long-lasting disability and at an increased risk of suffering a recurrent stroke. So few patients get the rehabilitation they need, and what they do get does little to improve their fitness, muscle strength and endurance, or reduce vascular risk factors. There is an urgent need for evidence-based rehabilitation interventions that promote recovery and reduce the risk of recurrent stroke. Exercise and physical activity is recommended after stroke, but unfortunately, it remains unclear what should be prescribed and when. Given my expertise in exercise physiology, I have a significant opportunity to make important contributions to the knowledge about exercise prescription and establishing a pathway from acute care to long-term health and well-being after stroke. This is a critical need for stroke survivors and will potentially transform the current rehabilitation landscape.

3. What have been the highs so far?

Stroke survivors want answers to questions such as what exercise they should be doing, how much and how hard they should exercise, and when should they begin exercise training. The fact that I am leading research that will hopefully answer these questions gives me enormous satisfaction. I also very much enjoy engaging with the participants in my studies – their support of my research is very humbling.

I also feel incredibly privileged to be working in a Research Institute that is the foremost stroke research centre in Australia. I am surrounded by amazing researchers and scientists that are passionate about finding ways of helping people with neurological and mental health conditions – every day is inspiring.

4. What have been the lows?

Navigating the challenges of being in research is a persistent battle. It has never been tougher to win grants to support your research, particularly for early career researchers. Knowing that your livelihood is dependent on that next grant is something I find very stressful.

I also struggle to deal with rejections from scientific publishers and near-misses from grant funders. The feeling of failure and not being good enough is pervasive in this line of work and can at times be overwhelming.

5. How do you balance work life with the needs of home life?

With difficulty actually! Firstly, I should say that I have tremendous support from my wife to do what I do, but I think, like many, I find this to be one of the most challenging aspects of research. I think just being mindful of trying to maintain a balance is important – and then putting in place some strategies to keep work and home life separate works reasonably well for me. I try to maintain pretty rigid routines with what I dedicate my time to and when, and I exercise every day which I find is super important for my physical and mental health. Weekends are primarily time for me and my family, and I make sure I take at least one-week away from work a couple of times a year, not only for me to refresh and recharge, but also to dedicate time to my marriage and fur-babies.

6. Who are your most important mentors and how did you find them?

I have been very fortunate to be mentored by a number of people, though mainly in informal arrangements, whereby I have come to them, as leaders in research I am interested in, for guidance. It is really only in hindsight that I consider people like Professors Frank Mastaglia, Gary Thickbroom and Dylan Edwards to have been fantastic mentors. Since moving to The Florey Institute, I have been incredibly fortunate to be supervised by Professor Julie Bernhardt, who I consider to be a mentor as much as my supervisor. Julie has been tremendously influential of me – her care, guidance and support drives me every single day to give the very best of myself to my work. Via the Florey Institute’s formal mentoring program, I have also been lucky to be mentored by Dr Lachlan Thompson more recently, which I am finding to be very helpful also.

7. What are your most important collaborations and how have you built them?


Building on the hard work and leadership of people like Professor Bernhardt, I have been privileged to access an extensive network of collaborators, in particular within the Centre of Research Excellence in Stroke Rehabilitation and Brain Recovery. I also collaborate with a number of other groups, including a group based in New York, USA, focussing on telemedicine and virtual rehabilitation, and a group researching exercise training for people with Parkinson’s disease at Deakin University. I believe that having a strong reputation for excellence and integrity in your research, being willing to work with others and open to opportunities, and being generous in the collaboration are some of the more important ingredients for initiating and establishing healthy collaborations.

Monday, January 18, 2016

Seven Minutes in Stroke: Valeria Caso

The International Journal of Stroke has incredible author and reviewer support from stroke experts around the world. Over the years I've interviewed, met with, emailed, conversed and conferenced with so many amazing people who's career path and study interest are so interesting these wonderful stories must be shared! So we have started a new blog series entitled Seven Minutes in Stroke'.

Our first 'Seven Minutes in Stroke' series kicks off with the inspiring Valeria Caso, President elect of the European Stroke Organisation.

Seven minutes in stroke

1. What inspired you towards neuroscience?
My interest for neuroscience was sparked by a conference on Childhood Neuropsychiatry that I attended during my last year of high school; listening to the speaker, showing the developmental phases of the brain and its pathologies, I knew that this was my calling.

2. Why stroke?
During my 2nd year of Neurological specialization my Director sent me to Germany,  my home country, to learn how to set up what would be the future Perugia Stroke Unit. During those 6 months, my passion for stroke care began.

3. What have been the highs so far?
Well, the Perugia Stroke Unit was established in 1998, so over the last 17 years the satisfying moments have been many. We adopted the stroke pathways that resulted in one of the lowest mortality rates in Italy. We have seen great advances in treatment which have saved, undoubtedly, hundreds of lives, as well as reducing significantly disability.

4. What have been the lows?
Still, people have not gotten the message that when they have symptoms of stroke they need to get to the hospital. In fact, because of this we see unnecessary victims of stroke.

5. How do you balance work life with the needs of home life?
I am very lucky because my family members are very supportive, especially my well-chosen husband.

6. Who are your most important mentors and how did you find them?
The first and most important is my friend and colleague Maurizio Paciaroni who was the first person I met at Clinica Neurologica. Over the last twenty years, we have been working side by side building up the Stroke Unit and carrying out research. Our dedication has produced many accomplishments in the field of stroke. The remaining three mentors have been Didier Leys, Werner Hacke and Michael Brainin who have provided me with professional opportunities that were important steps in my career. I am grateful for their genuine support and their trust.  

7. What are your most important collaborations and how have you built them?
Currently, my most important collaborations include those with healthcare professionals interested in nurturing the field of Women’s Medicine. This is because, we share the understanding  that there are inherent  differences between the sexes regarding responses to treatment, time of disease and outcome.  Building these collaborations has been possible through mutual integrity and passion for the patients. 

Monday, April 13, 2015

SAGE to begin publishing the International Journal of Stroke January 2016

Taken from the SAGE website!

http://www.uk.sagepub.com/aboutus/press/2015/apr/9.htm


London (April 9 2015)- SAGE, one of the world’s leading independent and academic publishers, has today announced that it is to publish the International Journal of Stroke,the official journal of the World Stroke Organization (WSO) incorporating the International Stroke Society (ISS) and the World Stroke Federation (WSF).

Focused on the clinical aspects of stroke, the International Journal of Stroke reviews not only current topics and recent advances of global interest, but also those which may be more prevalent to certain regions to help facilitate the international debate and awareness around stroke. The journal accepts leading opinion pieces, topical reviews and original contributions from clinical or basic science researchers, alongside pieces focused on the associated structures to manage protocols within the field. The journal is edited by the internationally recognised stroke expert Professor Geoffrey Donnan, who was awarded the prestigious Bethlehem Griffiths Research Foundation (BGRF) medal in 2008.
Speaking about the new partnership, Karen Phillips, Editorial Director, SAGE, remarked that:
“SAGE has developed a strong medical portfolio over the past decade and to have been selected to publish the International Journal of Stroke is a testament to the dynamic nature and breadth of our titles and an indication of our growing strength across these disciplines. We are delighted to be working closely with the leading editorial board and WSO to continue to support access to cutting edge research on stroke awareness, further developing the reach of the journal and making it an excellent platform for sharing international stroke research.”
The International Journal of Stroke Editor- in- Chief Geoffrey Donnan, further stated:
“We are thrilled to now be publishing with SAGE, a publisher whom we feel not only is closely aligned with both our editorial goals but who has proven itself a leader within the field, now being ranked in the top 4 for publication of medical journals. Their growing medical background and clear vision for our future development is what we are most looking forward to when we begin working together. With SAGE behind us we are confident in the continuation of our key aim: reducing the global burden of stroke through prevention, treatment and long term care.”
WSO President Professor Stephen Davis added:
“SAGE offered everything that we were looking for when finding a new home including: the opportunity for international development and a great understanding of the field in which the journal is situated. We are all excited at WSO about this new partnership with SAGE and delighted with the upward trajectory of our Journal as the truly global medium for stroke research and education.”

The first SAGE issue will publish in January 2016. Please click here for more information on the journal.
# # #
SAGE Founded 50 years ago by Sara Miller McCune to support the dissemination of usable knowledge and educate a global community, SAGE publishes more than 800 journals and over 800 new books each year, spanning a wide range of subject areas. A growing selection of library products includes archives, data, case studies, conference highlights and video. SAGE remains majority owned by our founder and after her lifetime will become owned by a charitable trust that secures the company’s continued independence. Principal offices are located in Los Angeles, London, New Delhi, Singapore, Washington DC and Boston.www.sagepub.com
The International Journal of Stroke is the flagship publication of the World Stroke Organization and publishes high quality research articles, reviews and clinical trial protocols from around the world. IJS is dedicated to building a global stroke community, making it a global voice for stroke research and an excellent platform for sharing international stroke research.
The World Stroke Organization (WSO) is the world’s leading organization in the fight against stroke. It was established in October 2006 through the merger of the International Stroke Society and the World Stroke Federation with the purpose of creating one world voice for stroke. Today, WSO has more than 2000 individual members and over 60 society members from 85 different countries. www.world-stroke.org


Thursday, February 5, 2015

What do Emilio Botin (Spanish banker), James Gandolfini (american actor) and my grandpa (argentine journalist) had in common? None should have died when they did….

They all suffered “heart attacks”. No details have been provided on Mr. Botin’s (79) death but according to a media source “it was totally unexpected” and “…it occurred a few hours before he would present a painting by Velázquez that he helped restore…”. Mr Gandolfini (51), well known for his role in the Soprano’s, was on vacation in Rome and planning to attend the closing of the Taormina Film festival in Sicily when his 13 year old son found him unconscious at their hotel’s bathroom. Resuscitation efforts at a hospital were unsuccessful. My grandfather (68) died of acute pulmonary oedema (i.e. acute heart failure) the day after he was planning to join a sports club…

Despite medical supervision (a cardiologist was “seeing” my grandfather), it is an epidemiologic fact common to most people above 40 years of age to have at least an untreated or undertreated vascular risk factor. Among the most common modifiable risk factors are inappropriate nutrition with or without excess weight, a sedentary life, current or recent smoking, high blood pressure (undiagnosed in 1 out of 3 people and uncontrolled in 80% of diagnosed patients in developed countries), abnormal lipid levels or diabetes. Also, Botín, Gandolfini and my grandfather shared a load of un-modifiable risk factors such as male sex, age and, potentially, a spectrum of unfavorable genetic traits. All these factors alter the normal arterial wall structure generating plaques that progressively narrow the vessel’s lumen leading to a decrease in blood flow to the heart, brain and other organs. 

The vascular problem is complex and dynamic. It is definitely not just a matter of clogged pipes. In fact, 80% of myocardial infarctions (MI’s) -with a high mortality rate- occur due to arteries that are not previously “stenotic” (i.e. narrowed). These patients will not be detected with a coronary “stress” test which only identifies arteries that have advanced narrowing and thus cannot supply enough blood to the heart muscle. Only 20% of MI’s occur in patients with previously narrowed arteries and these are the ones that can be detected by warning symptoms or a positive stress test. The concern, then, is that the vast majority of people have “plaques” covering the arterial wall (as dirt may accumulate in the walls of a plumbing system) which do not decrease the vessel’s diameter and are thus difficult to detect with conventional studies. The danger is that the so called “plaque accident” can unexpectedly occur leading to a sudden plaque disruption that generates a clogging cascade ending within minutes with a blocked artery… and an infarcted or dead person. A similar mechanism underlies many strokes. We have all heard people saying: “… how could this happen?… he/she was so healthy….”. In the case of James Gandolfini, the New York Times quoted that, after receiving results of the autopsy, a family member stated that he “…died… of natural causes”. Wrong! These people are sick and the essential -the status of their arteries- was invisible to the eye…


What Botín, Gandolfini and my grandpa did not know is that almost 80% of vascular events occur in people with few risk factors. This is the reason why most people feel that a heart attack or stroke is something that will happen “to others”. Yet, some people get health check-ups with the hope that if “approved” they get a few years’ survival guaranteed. Disappointingly, a Danish study on 180.000 people published recently in the British Medical Journal showed that conventional health check-ups (including a chest Xray, EKG, ultrasounds and blood tests among others) did not decrease total mortality or death secondary to cardiovascular disease or cancer, the very reasons for promoting and performing these evaluations (pap smear, mammogram, colonoscopy and prostate exams were excluded). So, what are we missing?

Could an eye doctor give you the right glass prescription without examining your eyes? The exact same rationale applies to disease of the arteries irrespective of whether they are in the heart, brain, legs or kidneys. Different methods can reliably evaluate arteries but most are expensive and some are invasive such as catheterization and others, like multi slice CT, use high doses of radiation precluding the repeated testing needed for disease follow-up. Ultrasound is fast, reliable, non invasive and affordable. There are ultrasound tests available that allow to objectively measure the atherosclerosis load in the vessel’s wall. Atherosclerotic plaque quantification was originally developed by David Spence in the 90’s and further studied by Valentin Fuster and others more recently. A quantification of arterial “plaque” burden (expressed in square or cubic millimeters depending on the technique) allows to accurately measuring the individual’s risk of having a vascular event. Knowing a person’s vascular risk factor profile (smoker, excess weight, hypertensive, etc) does not provide accurate data on that individual person’s risk of suffering a heart attack, stroke or other vascular event. In concordance with this notion, the latest lipid therapy guidelines recommend treatment according to the person’s vascular risk and not according to a specific cholesterol level. It is impossible to accurately define the best medical treatment based only on a person’s risk factor profile (or using “risk scores” which are derived from risk factor data) without measuring the load of atherosclerosis that affects the arteries. Vascular prevention should be based on a tailor made treatment. Or, again, could the eye doctor give you the right glass prescription just knowing you can’t see well (i.e. that you have vascular risk factors) without examining your eyes (i.e. your arteries)?

From Galileo Galilei to the software metrics guru Tom de Marco, many have stressed that one can only control what is measured. And everything is measurable. We should not only be measuring the conventional risk factors such as blood pressure, cholesterol, glucose, exercise and calories, but also the amount of atherosclerosis in the arteries. Only then we will be able to adjust the treatment of vascular risk factors “individually” according to all findings. The World Health Organization and different research authorities have shown that cardiovascular deaths could decrease by 80% if what we know about vascular disease was applied effectively. Botín, Gandolfini and my grandfather, no matter their wealth, social status or popularity were probably not receiving the medications and other measures (exercise, nutrition) that could have prevented their deadly vascular event. It is also unlikely that they had their “atherosclerosis” burden measured to adjust treatment according to their individual atherosclerosis load. There are millions more like them that every year have fatal MI’s and strokes. Of the approximately 150,000 people that die every day worldwide, almost one third dies of vascular related disease. Most of these deaths are preventable. It is due time to declare “tolerance zero” to unexpected vascular death.   

Conrado J. Estol, M.D., Ph.D.


Tuesday, January 20, 2015

The impact of MR CLEAN Editorial IJS


The impact of MR CLEAN 
This is the first opportunity I've had to comment on the recent presentation of the MR CLEAN results by Dr Diedrick Dippel from the Netherlands at the World Stroke Congress in Istanbul, 2014. As the stroke world now knows, the results of this well conducted randomized control trial of endovascular treatment in acute ischaemic stroke, most of whom had commenced intravenous tPA before randomization, was strongly positive. For the first time in my career I observed a standing ovation following a presentation, such was its impact. To have such a clear-cut result, after years of frustration with trials of neuro protection and even endovascular therapy, we now seem to be at a point where the second definite intervention of acute ischemic stroke is upon us. While it is true that we have two other proven interventions for acute ischaemic stroke vis management in a stroke unit and hemicraniectomy, endovascular therapy promises to be the most significant advance in the area since tPA in 1995–96.
Interestingly, the Data safety monitoring boards of trials such as EXTEND IA, SWIFT–PRIME and ESCAPE, reacting to the MR CLEAN results have suggested suspension of these trials, with steering committees recommending these trials now cease, the final results of many will be presented at the forthcoming ISC in Nashville, USA, this month.
More importantly, if the results of MRCLEAN are confirmed by other studies, a revolution of the delivery of stroke services is likely to occur. Specifically, the demand for interventional services is going to escalate almost exponentially so that centres of excellence will need to be established to cope with the throughput to maintain their high standards of excellence in service delivery. Governments around the world will need to response accordingly.
Taking a look at this edition, Patrick Lydens review Revisiting Cerebral Postischemic Reperfusion Injury: New Insights highlights that there is still much research to do to fully understand this process and offers targets for therapy as yet to be identified, the relevance relating to my earlier comments on endovascular therapy is obvious. Since with both tPA and endovascular therapy reperfusion injury is going to become an increasingly important topic; a review well worth reading. I also mentioned how surgical decompression for space-occupying middle cerebral artery infarction has become one of the proven interventions of definite benefit after acute ischemic strokes, albeit in a minority of patients. Hence, the systematic review of Middelar et al is a welcome supplement to a difficult area of research. Reassuringly, quality of life was reasonable amongst most patients receiving this intervention and severe decompressive symptoms were uncommon. This provides even more evidence to suggest that the procedure be performed much more frequently than it is in most centres around the world.
Our research papers this edition are of their usual high standard, and I'm delighted to have a Panorama telling us about the burden of stroke in Mexico, our protocols section, continues to be extremely popular with trials for Cilistozol, folic acid and b vitamins, among a number of secondary prevention studies.
Looking forward to seeing you at the inaugural European Stroke Organization Conference, which is the official European Stroke Conference.

Tuesday, December 23, 2014

We invite you to comment: The WSO Stroke Research Committee research recommendations relevant to the WSO mission for Stroke Treatment, Prevention and Recovery

The WSO Stroke Research Committee has been working to establish a set of research recommendations relevant to the WSO mission for Stroke Treatment, Prevention and Recovery.  In establishing these draft recommendations the committee systematically collated, categorized, and reviewed research recommendations from multiple other national, regional, and patient-centered stroke organizations.  The WSO Board members were asked to review and prioritize these research recommendations.  Recommendations were rated on how strongly they definitely should be included among the top recommendations related to the WSO mission.  The top recommendations are listed below:

Stroke Treatment
1. Expand and integrate existing stroke trial networks to accelerate translation
2. Establish stroke centers and stroke units to assist patients with acute stroke

Stroke Prevention
1. Establish a global chronic disease prevention initiative that includes stroke as a major focus among a cluster of conditions
2. Prevent vascular cognitive impairment

Stroke Recovery
1. Standardize the practice of post stroke rehabilitation based on best evidence
2. Evaluate of the best ways to address and improve life after stroke:
            (a) Improve cognition after stroke;
            (b) Help people come to terms with the long-term consequences of stroke;
            (c) Enhance recovery from aphasia; and
            (d) Improve arm recovery and function.


These draft recommendations approved by the WSO Board in October 2014 are now being posted for member and public comment.   At present, we request WSO members and other stroke constituents to review these draft recommendations and post any comments on the BLOG.  Comments will be collated and reviewed by the WSO Research Committee and included in their final report.  We will be accepting comments until Friday, January 23rd, 2015.







If you are having difficulty commenting then please feel free to email your comment directly to carmenl@unimelb.edu.au or on our Facebook 




Featured Post

Epidemiologic profiling for stroke in Nepal: Endeavour towards establishing database

Resha Shrestha  @avi_neuro. , MS 1 , Avinash Chandra, MD 1 , Samir Acharya, MS 1 , Pranaya Shrestha, MS 1 , Pravesh Rajbhandari, MS 1 , Re...